CDIO · Cardio Diagnostics Holdings, Inc.
Market Cap
$5.53M
Shares
2.96M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.85
Open$1.87
Day$1.81–1.87
52W close$1.05–6.55
Avg vol 30d84K
Short int30K · 1.0% float · 1.0d
Short vol60%
DataMay 2025–Sep 2026
Filing10-Q · Aug 7
Raw chart and full-history price indicators begin at the captured split on May 13, 2025; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 7, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−20%
below
Price vs 50-day avg
−0%
below
RSI (14)
49
neutral
MACD trend
Negative
52-week position
15%
near low
Momentum
relative strength
1-month return
+6%
trailing
6-month return
−61%
trailing
YTD return
−32%
this year
Relative strength
−74%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.00% of float · ▲ +24.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
22 holders — mid 3-yr range
Squeeze score
53
elevated · 0–100
Fundamentals
Revenue growth
−58%
Y/Y
EPS growth
+60%
Y/Y
Free cash flow
$-5.9M
Quant / Vol
risk profile
Volatility
149%
annualized · 1-yr
Max drawdown
−79%
past year
ATR
8.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−20%
Bearish
Price vs 50-day avg
−0%
Neutral
RSI (14)
49
Neutral
MACD trend
Negative
Bearish
52-week position
15%
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.00% of float · ▲ +24.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
22 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $2 · 15%
Range high $7
vs 200-day avg -20%
vs 50-day avg 0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CDIO
this stock
Cardio Diagnostics Holdings, Inc.
|
$5.53M | -31.7% | -57.5% | — | 1.0% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +20.8% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +6.7% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$64.16B | +22.3% | — | — | 1.9% |
|
MRNA
Moderna, Inc.
|
$61.59B | +423.1% | +4.3% | — | 13.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
Raw-price comparisons begin at the captured split on May 13, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CDIO | -3.1% | +6.3% | -61.1% | -1.1% | -31.7% |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | -2.6% | +7.6% | -73.8% | -0.4% | -43.4% |
Key facts
CIK
1870144
CUSIP
14159C202
13F (30d)
21 filings
21 filers
Visit website
Investor relations